Novanta is trading at $150.12, down 4.40%, as the broader market rises.
- No clear company-specific announcement or catalyst was identified for August 19, 2026.
- Recent Q2 results and raised full-year guidance were positive, including revenue guidance of $1.13 billion-$1.14 billion.
- Novanta fell 6.90% on August 18, 2026.